News
Sports
Life
Opinion
Business
Advertise
Obituaries
eNewspaper
Legals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Collegium Pharma
(NQ:
COLL
)
38.60
+3.71 (+10.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Collegium Pharma
< Previous
1
2
Next >
NASDAQ:COLL is an undervalued gem with solid fundamentals.
July 16, 2024
COLLEGIUM PHARMACEUTICAL INC (NASDAQ:COLL) is probably undervalued for the fundamentals it is displaying.
Via
Chartmill
Dr. Reddy's Labs Stock Sees Improved Technical Strength
June 28, 2024
On Friday, Dr. Reddy's Labs ADR stock earned an upgrade to its Relative Strength (RS) Rating, from 66 to 76.
Via
Investor's Business Daily
7 Biotech Stocks to Buy on the Dip: June 2024
June 24, 2024
With health being a top priority over wealth generation, these biotech stocks to buy on the dip enjoy a sound framework for speculation.
Via
InvestorPlace
NASDAQ:COLL appears to be flying under the radar despite its strong fundamentals.
June 24, 2024
COLLEGIUM PHARMACEUTICAL INC (NASDAQ:COLL) is an undervalued gem with solid fundamentals.
Via
Chartmill
Demystifying Collegium Pharmaceutical: Insights From 4 Analyst Reviews
May 10, 2024
Via
Benzinga
COLL Stock Earnings: Collegium Pharmaceutical Beats EPS, Misses Revenue for Q1 2024
May 09, 2024
COLL stock results show that Collegium Pharmaceutical beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Critical Insights From Collegium Pharmaceutical Analyst Ratings: What You Need To Know
April 11, 2024
Via
Benzinga
Where Collegium Pharmaceutical Stands With Analysts
February 23, 2024
Via
Benzinga
Recap: Collegium Pharmaceutical Q4 Earnings
February 22, 2024
Via
Benzinga
Analyst Expectations For Collegium Pharmaceutical's Future
February 02, 2024
Via
Benzinga
Why Collegium Pharmaceutical Shares Are Gaining Today
January 03, 2024
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) today announced FY24 financial
Via
Benzinga
TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday
January 03, 2024
U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) rose sharply during Wednesday’s session after it disclosed receiving a...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Recap: Collegium Pharmaceutical Q3 Earnings
November 07, 2023
Via
Benzinga
Needham Maintains Buy Rating for Collegium Pharmaceutical: Here's What You Need To Know
August 25, 2023
Via
Benzinga
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
August 04, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Recap: Collegium Pharmaceutical Q1 Earnings
May 04, 2023
Via
Benzinga
Earnings Outlook For Collegium Pharmaceutical
February 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 07, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
February 07, 2023
It's time to start the day with a breakdown of the biggest pre-market stock movers investors will want to watch on Tuesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
February 06, 2023
Via
Benzinga
Analyst Sees This 'Specialty Pharma' Stock Stuck Until Prescription Trends Improve
August 08, 2022
Via
Benzinga
Recap: Collegium Pharmaceutical Q1 Earnings
May 10, 2022
Collegium Pharmaceutical (NASDAQ:COLL) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Collegium Pharmaceutical's Shares Are Trading Higher Today
April 05, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
August 08, 2022
Via
Benzinga
7 Micro-Cap Stocks to Take a Chance on Now
June 04, 2022
Despite (or because of) their size, some micro-cap stocks, have good value and are overlooked and should be considered by investors.
Via
InvestorPlace
A Preview Of Collegium Pharmaceutical's Earnings
May 09, 2022
Collegium Pharmaceutical (NASDAQ:COLL) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
May 09, 2022
What Defines a Value Stock?
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
May 02, 2022
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...
Via
Benzinga
Analyst Ratings For Collegium Pharmaceutical
April 06, 2022
Over the past 3 months, 4 analysts have published their opinion on Collegium Pharmaceutical (NASDAQ:COLL) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.